During the past decade, General Hospital Hietzing conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "General Hospital Hietzing" #1 collaborator was "Clinipace Worldwide" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "General Hospital Hietzing" are "Acute Myeloid Leukemia" (2 trials), "Chronic Myelomonocytic Leukemia" (1 trials), "Multiple Myeloma" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "General Hospital Hietzing" in a lesser frequency.

Most popular intervention types in "General Hospital Hietzing" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "ASTX727" (1 trials), "Azacitidine" (1 trials), "Bortezomib" (1 trials), "Dacogen" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "General Hospital Hietzing" are 3 trials for "All" genders.

Currently, there are NaN active trials in "General Hospital Hietzing". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in General Hospital Hietzing, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in General Hospital Hietzing, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".